entertainment -WSS

entertainment

author：focus 2025-09-28 00:53:49 - browse：95

Insitro CEO and founder Daphne Koller Neilson Barnard/Getty Images for The New York Times

SAN FRANCISCO — It took only a single, one-hour meeting in a Starbucks to convince venture capitalist Robert Nelsen that he was going to invest in the company being built by machine-learning whiz Daphne Koller. “She’s just an amazing force of nature,” said Nelsen, who invests for ARCH Venture Partners.

Koller’s company, Insitro, in a matter of months raised over $100 million from big-name investors including ARCH, Foresite Capital, Andreessen Horowitz, and the firm that manages Jeff Bezos’ personal VC investments. (Koller refers to Bezos by his first name.) Now, it’s time for the next step. On Tuesday, the giant drug maker Gilead Sciences said it would pay Insitro $15 million — and up to $1 billion more down the line if it meets certain goals — for help in developing drugs to treat a common liver disease. It is the South San Francisco-based company’s first deal with a drug maker, and offers a test of whether artificial intelligence can remake drug development.

The very nature of the financials emphasize the exciting but risky reality: The technology has great promise, but nothing is guaranteed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： How one patient went off dialysis — and others can too

entertainment

Wikipedia

WSS

Biogen shutters digital health group, ends Apple study, in cost cutting move

Listen: Who gets the credit for GLP

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Sudafed saga points to U.S. issues with evaluating older drugs

Senator probes 340B programs at Cleveland Clinic, Bon Secours

After a drawn out lobbying fight, ARPA

Wikipedia

entertainment

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Cancer drug shortages should be causing more outrage

WHO recommends dropping component of many flu vaccines

Trump demands the U.S. pay no more for drugs than other countries … again

Synthetic human embryos? Researchers say term is overblown

Duchenne breakthrough therapy leaves behind pioneering families

Tuskegee Airman Raymond Cassagnol dies at 102

Drug repurposing or repositioning? The language matters

Ukrainian soldiers say they owe lives to US

Wikipedia

Illumina to lay off 10% of research and development team

Health tech startups drop sharply from 2021 highs

ADA: All diabetes patients should be screened for liver condition

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Eating disorder hotline's move to chatbot carried cost for volunteers

Sudafed saga points to U.S. issues with evaluating older drugs

focus

entertainment

Wikipedia

hotspot